Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, […]
Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, […]
This third session in the BAHNO MDT Interface Series focuses on the challenge of mental health in Head & Neck Cancer. It will explore how members of the MDT can […]
Save the date for the ESMO Immuno-Oncology Congress 2025, taking place from 10 until 12 December 2025 as an onsite event in London, UK, as well as online. This international […]
HLH ccEvent Overview Date: 12 December 2025 Time: 9am - 5pm Venue: America Square, Cavendish Venues CPD: 6 credits A one-day in-person study day hosted by The HLH Imaging Group […]
Overview This study day will focus on important approaches to management of patients with secondary (or metastatic) breast cancer. Topics will include all aspects of the patient pathway, Including recent […]
An annual conference that brings together cancer researchers and stakeholders from across the UK. The Wales Cancer Research Conference is an opportunity for cancer researchers in Wales to convene across […]
Overview Advances in cancer treatments mean that more people are living longer, even with incurable disease. This has uncovered a need to review our approach to cancer pain management , […]
Overview This is a two day course which will present a basic understanding of cancer. Through a series of presentations David describes how cancer develops, the commonest types of cancer, […]
The 9th DDR Inhibitors Summit returns to Boston in 2026 as the leading event uniting biopharma, biotech, and academia to advance next-generation DNA Damage Response (DDR)-targeted therapies beyond PARP. With […]
This course introduces the biology and genetics of many haematological cancers. Elaine also describes a wide range of systemic treatment approaches for acute and chronic leukaemia, non-Hodgkin and Hodgkin lymphoma, […]
We will focus on the latest evidence base in the managements of these aggressive cancers, surgical and oncological considerations, and technological advances. The participants will leave the meeting with clear […]
